Skip to content

Clinical trials

Glucose Metabolism Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glucose Metabolism Disorders Clear all

361 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20014
20021
20037
20046
20055
200614
200712
20089
200910
201010
20119
20128
201311
201415
201514
201621
201726
201824
201921
202020
202116
202220
202326
202426
20259
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed226
Unknown status47
Recruiting26
Terminated26
Active, not recruiting17
Not yet recruiting9
Withdrawn7
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda41
Eli Lilly and Company12
University Hospital, Gentofte, Copenhagen9
Pfizer7
AstraZeneca6
Hvidovre University Hospital6
Maastricht University Medical Center5
Merck Sharp & Dohme LLC5
Ultragenyx Pharmaceutical Inc5
University of Aarhus5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glucose Metabolism Disorders361
Diabetes Mellitus154
Diabetes Mellitus, Type 2135
Metabolic Diseases125
Endocrine System Diseases98
Insulin Resistance49
Dyslipidemias47
Diabetes Mellitus, Type 136
Obesity30
Diabetes Mellitus, Lipoatrophic27

Trials

Showing 26 to 50 of 361. Each trial links to its page on Pharma Observatory.

261 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.